chr3-7519462-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.1515+57740G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.623 in 151,992 control chromosomes in the GnomAD database, including 30,529 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 30529 hom., cov: 32)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.547

Publications

5 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.1515+57740G>T
intron
N/ANP_000835.1Q14831-1
GRM7
NM_181874.3
c.1515+57740G>T
intron
N/ANP_870989.1Q14831-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.1515+57740G>T
intron
N/AENSP00000350348.4Q14831-1
GRM7
ENST00000389336.8
TSL:1
c.1515+57740G>T
intron
N/AENSP00000373987.4Q14831-5
GRM7
ENST00000389335.7
TSL:1
n.1515+57740G>T
intron
N/AENSP00000373986.3Q14831-4

Frequencies

GnomAD3 genomes
AF:
0.623
AC:
94596
AN:
151874
Hom.:
30482
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.797
Gnomad AMI
AF:
0.534
Gnomad AMR
AF:
0.597
Gnomad ASJ
AF:
0.631
Gnomad EAS
AF:
0.470
Gnomad SAS
AF:
0.646
Gnomad FIN
AF:
0.490
Gnomad MID
AF:
0.621
Gnomad NFE
AF:
0.554
Gnomad OTH
AF:
0.607
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.623
AC:
94707
AN:
151992
Hom.:
30529
Cov.:
32
AF XY:
0.618
AC XY:
45937
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.797
AC:
33068
AN:
41472
American (AMR)
AF:
0.598
AC:
9128
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.631
AC:
2192
AN:
3472
East Asian (EAS)
AF:
0.471
AC:
2434
AN:
5172
South Asian (SAS)
AF:
0.647
AC:
3118
AN:
4822
European-Finnish (FIN)
AF:
0.490
AC:
5155
AN:
10520
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.554
AC:
37662
AN:
67952
Other (OTH)
AF:
0.608
AC:
1282
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1735
3470
5204
6939
8674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.606
Hom.:
20716
Bravo
AF:
0.636
Asia WGS
AF:
0.574
AC:
1997
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.93
DANN
Benign
0.48
PhyloP100
-0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756084; hg19: chr3-7561149; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.